AVANOS MEDICAL, INC.
AVNSNYSE
$24.97
↑ +0.0%Jul 17 close · end-of-day
Price
1Y↑ +117.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.2B
Enterprise Value
$1.2B
P/E
—
P/S
1.7
P/B
1.5
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$715.9M
Net Income (TTM)
-$74.4M
Free Cash Flow (TTM)
—
Gross Margin
50.0%
Operating Margin
-8.8%
Net Margin
-10.4%
ROE
-9.5%
ROIC
-6.2%
Debt / Equity
0.1
Net Cash
-$21.7M
Return 1Y
+114.5%
Company profile
Avanos Medical, Inc. focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including acute pain products.
- CEO
- Joseph F. Woody
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 4,040
- Headquarters
- Georgia
- Website
- avanos.com
Management & directors
- Delgado SigfridoSVP, Operations
- Galovan Scott MichaelSVP, Chief Financial Officer
- Pacitti DavidChief Executive Officer
- Hurley John JosephPrincipal Accounting Officer
- Holbrook KerrSVP, Chief Commercial Officer
Roles derived from SEC Form 4 filings.
Earnings
AVNS Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$182.2M↑ +8.8%
Diluted EPS$0.11↓ -21.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $714.8M | $587.0M | $684.1M | $673.3M | $687.8M | $701.2M |
| Gross profit | $370.9M | $299.2M | $394.2M | $379.7M | $381.3M | $353.9M |
| Operating income | -$48.5M | -$39.0M | $35.5M | $4.2M | -$396.2M | -$61.6M |
| Net income | -$29.0M | $6.3M | $50.5M | -$61.8M | -$392.1M | -$72.9M |
| Diluted EPS | -$0.61 | $0.13 | $1.07 | -$1.32 | -$8.53 | -$1.57 |
| Operating cash flow | -$2.5M | $87.3M | $90.9M | $32.4M | $100.7M | $74.7M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 51.9% | 51.0% | 57.6% | 56.4% | 55.4% | 50.5% |
| Operating margin | -6.8% | -6.6% | 5.2% | 0.6% | -57.6% | -8.8% |
| Net margin | -4.1% | 1.1% | 7.4% | -9.2% | -57.0% | -10.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $171.7M | $170.4M | $179.6M | $167.5M | $175.0M | $177.8M | $180.9M | $182.2M |
| Gross profit | $95.6M | $92.9M | $98.0M | $89.8M | $92.1M | $86.0M | $86.0M | $94.2M |
| Operating income | $6.3M | $12.0M | -$418.5M | $10.3M | -$74.5M | $100,000.00 | $2.5M | $8.9M |
| Net income | $1.8M | $4.3M | -$397.3M | $6.6M | -$76.8M | -$1.4M | -$1.3M | $5.1M |
| Diluted EPS | $0.04 | $0.09 | -$8.64 | $0.14 | -$1.66 | -$0.03 | -$0.02 | $0.11 |
| Operating cash flow | $27.8M | $23.0M | $57.9M | $25.7M | $6.8M | $14.0M | $28.2M | -$12.3M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 55.7% | 54.5% | 54.6% | 53.6% | 52.6% | 48.4% | 47.5% | 51.7% |
| Operating margin | 3.7% | 7.0% | -233.0% | 6.1% | -42.6% | 0.1% | 1.4% | 4.9% |
| Net margin | 1.0% | 2.5% | -221.2% | 3.9% | -43.9% | -0.8% | -0.7% | 2.8% |
Company news
Jun 29, 2026
Jun 24, 2026
Jun 4, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-22 | Delgado Sigfrido· SVP, Operations | Tax withholding | 4,264 | $24.64 | $105,064.96 | filing |
| 2026-04-22 | Galovan Scott Michael· SVP, Chief Financial Officer | Tax withholding | 4,228 | $24.64 | $104,177.92 | filing |
| 2026-04-14 | Pacitti David· Chief Executive Officer | Tax withholding | 21,194 | $14.53 | $307,948.82 | filing |
| 2026-03-13 | Pacitti David· Chief Executive Officer | Award | 101,341 | $0.00 | $0.00 | filing |
| 2026-03-13 | Delgado Sigfrido· SVP, Operations | Award | 15,886 | $0.00 | $0.00 | filing |
| 2026-03-13 | Galovan Scott Michael· SVP, Chief Financial Officer | Award | 29,481 | $0.00 | $0.00 | filing |
| 2026-03-13 | Hurley John Joseph· Principal Accounting Officer | Award | 2,211 | $0.00 | $0.00 | filing |
| 2026-03-13 | Galovan Scott Michael· SVP, Chief Financial Officer | Award | 29,481 | $0.00 | $0.00 | filing |
| 2026-03-13 | Pacitti David· Chief Executive Officer | Award | 101,341 | $0.00 | $0.00 | filing |
| 2026-03-13 | Delgado Sigfrido· SVP, Operations | Award | 15,886 | $0.00 | $0.00 | filing |
| 2026-03-13 | Pacitti David· Chief Executive Officer | Award | 101,341 | $0.00 | $0.00 | filing |
| 2026-03-13 | Delgado Sigfrido· SVP, Operations | Award | 15,886 | $0.00 | $0.00 | filing |
| 2026-03-13 | Galovan Scott Michael· SVP, Chief Financial Officer | Award | 29,481 | $0.00 | $0.00 | filing |
| 2026-03-09 | Galovan Scott Michael· SVP, Chief Financial Officer | Tax withholding | 1,119 | $13.29 | $14,871.51 | filing |
| 2026-03-09 | Hurley John Joseph· Principal Accounting Officer | Tax withholding | 226 | $13.29 | $3,003.54 | filing |
| 2026-03-06 | Galovan Scott Michael· SVP, Chief Financial Officer | Option exercise | 5,907 | $13.79 | $81,457.53 | filing |
| 2026-03-06 | Galovan Scott Michael· SVP, Chief Financial Officer | Tax withholding | 2,356 | $13.79 | $32,489.24 | filing |
| 2026-03-06 | Galovan Scott Michael· SVP, Chief Financial Officer | Tax withholding | 2,041 | $13.79 | $28,145.39 | filing |
| 2026-03-06 | Galovan Scott Michael· SVP, Chief Financial Officer | Tax withholding | 1,057 | $13.79 | $14,576.03 | filing |
| 2026-03-06 | Hurley John Joseph· Principal Accounting Officer | Option exercise | 919 | $13.79 | $12,673.01 | filing |
| 2026-03-06 | Hurley John Joseph· Principal Accounting Officer | Tax withholding | 321 | $13.79 | $4,426.59 | filing |
| 2026-03-06 | Hurley John Joseph· Principal Accounting Officer | Tax withholding | 211 | $13.79 | $2,909.69 | filing |
| 2026-03-06 | Hurley John Joseph· Principal Accounting Officer | Tax withholding | 144 | $13.79 | $1,985.76 | filing |
| 2025-11-18 | Holbrook Kerr· SVP, Chief Commercial Officer | Sale | 13,834 | $11.00 | $152,174.00 | filing |
| 2025-11-18 | Holbrook Kerr· SVP, Chief Commercial Officer | Sale | 761 | $11.01 | $8,378.61 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.